PureTech Health Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Rob Lyne
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2yrs |
| Board average tenure | 5.5yrs |
Recent management updates
Recent updates
CEO
Rob Lyne (42 yo)
Mr. Robert Lyne, JD, also known as Rob, is Director of Seaport Therapeutics, Inc. from March 2026. He is Chief Executive Officer and Director at PureTech Health plc since December 18, 2025. He served as Ch...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | no data | US$618.63k | 1.47% $ 5.5m | |
| Co-Founder & Non-Executive Director | no data | US$270.00k | 1.35% $ 5.0m | |
| CEO & Director | less than a year | no data | no data | |
| Co-Founder & President | 1.9yrs | no data | no data | |
| Co-Founder & Senior Advisor | no data | no data | no data | |
| Chief Financial Officer | 1.3yrs | no data | no data | |
| Chief Accounting Officer | 1yr | no data | no data | |
| Senior VP of Communications & Head of Investor Relations | no data | no data | no data | |
| General Counsel & Company Secretary | 2.2yrs | no data | no data | |
| Executive Vice President of Human Resources | 5.7yrs | no data | no data | |
| Head of Oncology | 5.7yrs | no data | no data | |
| Senior Vice President of Intellectual Property | 5.7yrs | no data | no data |
Experienced Management: PTCH.F's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Non-Executive Director | no data | US$270.00k | 1.35% $ 5.0m | |
| CEO & Director | less than a year | no data | no data | |
| Co-Founder & Senior Advisor | no data | no data | no data | |
| Board Observer | 10.3yrs | no data | no data | |
| Senior Independent Director | 17.2yrs | US$290.00k | 0.65% $ 2.4m | |
| Board Advisor | 10.3yrs | no data | no data | |
| Independent Non-Executive Director | 5.5yrs | US$235.00k | 0.021% $ 76.6k | |
| Independent Non-Executive Director | 1.5yrs | US$123.65k | 0.012% $ 45.0k | |
| Independent Interim Chair | 4yrs | US$260.00k | 0.067% $ 250.7k |
Experienced Board: PTCH.F's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/23 14:02 |
| End of Day Share Price | 2026/03/16 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PureTech Health plc is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Welford | Jefferies LLC |
| Miles Dixon | Peel Hunt LLP |
| Edward Tenthoff | Piper Sandler Companies |